期刊文献+

甲状腺肿瘤与细胞因子IL-4、IL-10、IFN-γ、IL-17关系研究进展 被引量:6

下载PDF
导出
摘要 现有临床研究表明细胞因子在机体肿瘤的发生、发展过程中发挥重要作用[1],细胞因子是低分子量蛋白质家族成员,在免疫细胞的分裂、迁徙、生长、分化及凋亡过程中相互作用,形成了一个特定的网络。甲状腺肿瘤是内分泌系统常见的肿瘤,占头颈部肿瘤的首位。按其组织发生学、细胞分化程度和生物学特性,甲状腺肿瘤可分为良性肿瘤和恶性肿瘤,大多数为良性肿瘤。近几年来,甲状腺肿瘤发病呈上升趋势,女性明显多于男性,已经成为发病率增长最快的肿瘤[2]。目前。
出处 《河北北方学院学报(自然科学版)》 2015年第3期102-105,共4页 Journal of Hebei North University:Natural Science Edition
  • 相关文献

参考文献21

  • 1邓红添.复发性甲状腺癌与Th1/Th2的相关性研究[J].中国医疗前沿,2013,8(10):59-59. 被引量:1
  • 2Weaver CT,Hatton RD,Mangan PR,et al.IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annual Review of Immunology . 2007
  • 3Jebreel A,Mistry D,Loke D,Dunn G,Hough V,Oliver K,Stafford N,Greenman J.Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer. Journal of Laryngology and Otology . 2006
  • 4V. Bermúdez-Morales,O. Peralta-Zaragoza,J. Alcocer?González,J. Moreno,V. Madrid-Marina.IL-10 expression is regulated by HPV E2 protein in cervical cancer cells[J]. Molecular Medicine Reports . 2011 (2)
  • 5Jiankun Liu,Yuzhong Duan,Xiaoming Cheng,Xi Chen,Wei Xie,Haixia Long,Zhihua Lin,Bo Zhu.IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma[J]. Biochemical and Biophysical Research Communications . 2011 (2)
  • 6高萌,云升.IFN-λs抗肿瘤机制的研究进展[J].现代肿瘤医学,2014,22(2):466-469. 被引量:2
  • 7ZhaoJing Wang,Yifeng Yuan,Haiwen Zhuang.Hepatic haemangiomas: possible association with IL-17. JOURNAL OF CLINICAL PATHOLOGY . 2012
  • 8Eijun Itakura,Rong-Rong Huang,Duan-Ren Wen,Eberhard Paul,Peter H Wünsch,Alistair J Cochran.IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence. Modern Pathology . 2011
  • 9Herskind Carsten,Fleckenstein Katharina,Lohr Jens,Li Chuan-Yuan,Wenz Frederik,Lohr Frank.[Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis]. Strahlentherapie und Onkologie : Organ der Deutschen R?ntgengesellschaft ... [et al] . 2004
  • 10Masahiko Shibata,Takeshi Nezu,Hisao Kanou,Hideo Abe,Motoo Takekawa,Masahiro Fukuzawa.Decreased Production of Interleukin-12 and Type 2 Immune Responses Are Marked in Cachectic Patients with Colorectal and Gastric Cancer[J]. Journal of Clinical Gastroenterology . 2002 (4)

二级参考文献137

  • 1Kondo T, Ezzat S, Asa SL, et al. Pathogenetic mechanisms in thyroid follicular-cell neoplasia|J]. Nat Rev Cancer, 2006, 6 (4): 292-306.
  • 2Peyssonnaux C, Eychene A. The Raf/MEK/ERK path-way: new concepts ofactivation[J].BiolCell, 2001, 93 (1/2): 53-62.
  • 3Kim SK, Song KH, Lira SD, et al. Clinical and pathological features and the BRAF (V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis[J]. Thyroid, 2009, 19 (2): 137-141.
  • 4Hilger RA, Scheulen ME, Strmnberg D. The Ras-Raf-MEK-ERK pathway in the treatment of cancer [J]. Oncology, 2002, 25 (6): 511-518.
  • 5Salvatore G, Giannini R, Faviana P, et al. Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma[J]. Clin Endocfinol Metab, 2004, 89(10): 5175-5180.
  • 6Nikiforova MN, Kimura ET, Gandhi M, et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas[J]. J Clin Endocrinol Metab, 2003, 88 (11): 5399-5404.
  • 7Xing M, Westra WH, Tufano RP, et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer[J]. J Clin EndocfinolMetab, 2005, 90(12): 6373-6379.
  • 8Lee X, Gao M, Ji Y, et al. Analysis of differential BRAF (V600E) mutational status in high aggressive papillary thyroid microcarcinoma[J]. Ann Surg Oneol, 2009, 16 (2): 240-245.
  • 9Lee S, Hong SW , Moon WC. High prevalence of c-RET expression in papillary thyroid carcinomas from the Korean population[J]. Thyroid, 2005, 15 (3): 259-266.
  • 10Knauf JA, Ouyang B, Croyle M, et al. Acute expression of RET/PTC induces isozyme-specific activation and subsequent downregulation of PKC epsilon in PCCL3 thyroid cells [J]. Oncogene, 2003, 22 (44), 6830-6838.

共引文献12

同被引文献46

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部